Chemistry:SCHEMBL5334361

From HandWiki
Short description: Drug
SCHEMBL5334361
SCHEMBL5334361.svg
Identifiers
CAS Number
PubChem CID
Chemical and physical data
FormulaC18H21NO2
Molar mass283.371 g·mol−1
3D model (JSmol)

SCHEMBL5334361 is a drug which acts as an agonist at the 5-HT2 family of serotonin receptors, and was developed for the treatment of glaucoma. It is a benzazepine derivative structurally related to the anorectic drug lorcaserin. It is selective for 5-HT2A, with an EC50 of 0.4nM at 5-HT2A vs 3.9nM at 5-HT2C and a much lower affinity of 417nM at 5-HT2B.[1]

See also

References

  1. Mohapatra S, Hellberg MR, Feng Z, "Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma", WO patent 2007149728, assigned to Alcon Manufacturing, Ltd.